Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice

Cellular Microbiology

Volumn 7, Issue 3, 2005, Pages 383-392

  Lang, Thierry ^a   Goyard, Sophie ^a   Lebastard, Mai ^a   Milon, Geneviève ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTILEISHMANIAL AGENT; LUCIFERASE; PENTAMIDINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BIOLUMINESCENCE; CAMERA; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE TECHNIQUE; DISEASE COURSE; DRUG EFFICACY; DRUG MONITORING; DRUG SCREENING; FEMALE; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA; LEISHMANIASIS; LYMPH NODE; MACROPHAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; FEMALE; LEISHMANIA; LEISHMANIASIS; LUCIFERASES, FIREFLY; LUMINESCENT MEASUREMENTS; MACROPHAGES; MICE; MICE, INBRED BALB C; TRANSFECTION; TRYPANOCIDAL AGENTS;

EID: 14044270112     PISSN: 14625814     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2004.00468.x     Document Type: Article

References (43)

1. Antoine, J.-C., Jouanne, C., and Ryter, A. (1989) Megasomes as the talks of leucine methyl ester in Leishmania amazonensis amastigotes. Parasitology 99: 1-9.
2. Antoine, J.-C., Jouanne, C., Lang, T., Prina, E., de Chastellier, C., and Frehel, C. (1991) Localization of major histocompatibility complex class II molecules in phagolysosomes of murine macrophages infected with Leishmania amazonensis. Infect Immun 59: 764-775.
3. Berman, J.D. (1984) Leishmania tropica: quantitation of in vitro activity of antileishmanial agents by Giemsa staining, viability, and 3H-formycin B incorporation. J Parasitol 70: 561-562.
4. Blackwell, J.M. (1996) Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 112: S67-S74.
5. Buckner, F.S., Verlinde, C.L., La Flamme, A.C., and Van Voorhis, W.C. (1996) Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrob Agents Chemother 40: 2592-2597.
6. Buffet, P.A., Sulahian, A., Garin, Y.J., Nassar, N., and Derouin, F. (1995) Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother 39: 2167-2168.
7. Callahan, H.L., Portal, A.C., Devereaux, R., and Grogl, M. (1997) An axenic amastigote system for drug screening. Antimicrob Agents Chemother 41: 818-822.
8. Chan, M.M.Y., Bulinski, J.C., Chang, K.P., and Fong, D. (2003) A microplate assay for Leishmania amazonensis promastigotes expressing multimeric green fluorescent protein. Parasitol Res 89: 266-271.
9. Collins, L.A., Torrero, M.N., and Franzblau, S.G. (1998) Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis. Antimicrob Agents Chemother 42: 344-347.
10. Contag, C.H., Contag, P.R., Mullins, J.I., Spilman, S.D., Stevenson, D.K., and Benaron, D.A. (1995) Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 18: 593-603.
11. Courret, N., Fréhel, C, Prina, E., Lang, T., and Antoine, J.-C. (2001) Kinetics of the intracellular differentiation of Leishmania amazonensis and internalization of host MHC molecules by the intermediate parasite stages. Parasitology 122: 263-279.
12. Courret, N., Lang, T., Milon, G., and Antoine, J.C. (2003) Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice. Int J Parasitol 33: 1373-1383.
13. Deb, D.K., Srivastava, K.K., Srivastava, R., and Srivastava, B.S. (2000) Bioluminescent Mycobacterium aurum expressing firefly luciferase for rapid and high throughput screening of antimycobacterial drugs in vitro and in infected macrophages. Biochem Bioph Res Co 279: 457-461.
14. Doyle, T.C., Burns, S.M., and Contag, C.H. (2004) In vivo bioluminescence imaging for integrated studies of infection. Cellular Microbiol 6: 303-317.
15. Edinger, M., Hoffmann, P., Contag, C.H., and Negrin, R.S. (2003) Evaluation of effector cell fate and function by in vivo bioluminescence imaging. Methods 31: 172-179.
16. Ephros, M., Bitnun, A., Shaked, P., Waldman, E., and Zilberstein, D. (1999) Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes. Antimicrob Agents Chemother 43: 278-282.
17. Fakhfakh, M.A., Fournet, A., Prina, E., Mouscadet, J.F., Franck, X., Hocquemiller, R., and Figadere, B. (2003) Synthesis and biological evaluation of substituted quinolines: Potential treatment of protozoal and retroviral co-infections. Bioorg Med Chem 11: 5013-5023.
18. Francis, K.P., Joh, D., Bellinger-Kawahara, C., Hawkinson, M.J., Purchio, T.F., and Contag, P.R. (2000) Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect Immun 68: 3594-3600.
19. Francis, K.P, Yu, J., Bellinger-Kawahara, C., Joh, D., Hawkinson, M.J., Xiao, G., et al. (2001) Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect Immun 69: 3350-3358.
20. Goyard, S., Segawa, H., Gordon, J., Showalter, M., Duncan, R., Turco, S.J., and Beverley, S.M. (2003) An in vitro system for developmental and genetic studies of *Leishmania* donovani phosphoglycans. Mol Biochem Parasitol 130: 31-42.
21. Greer, L.F., and Szalay, A.A. (2002) Imaging of light emission from the expression of luciferases in living cells and organisms: a review. Luminescence 17: 43-74.
22. Handman, E. (2001) Leishmaniasis: Current Status of Vaccine Development. Clin Microbiol Rev 14: 229-243.
23. Jacobs, W.R., Barletta, R.G., Udani, R., Chan, J., Kalkut, G., Sosne, G., et al. (1993) Rapid assessment of drug susceptibilities of mycobacterium-tuberculosis by means of Luciferase Reporter Phages. Science 260: 819-822.
24. Kadurugamuwa, J.L., Sin, L., Albert, E., Yu, J., Francis, K., DeBoer, M., et al. (2003) Direct continuous method for monitoring biofilm infection in a mouse model. Infect Immun 71: 882-890.
25. Katakura, K., Kawazu, S., Naya, T., Nagakura, K., Ito, M., Aikawa, M., et al. (1998) Diagnosis of kala-azar by nested PCR based on amplification of the Leishmania mini-exon gene. J Clin Microbiol 36: 2173-2177.
26. Launois, P., Louis, J.A., and Milon, G. (1997) The fate and persistence of Leishmania major in mice of different genetic backgrounds: an example of exploitation of the immune system by intracellular parasites. Parasitology 115: S25-S32.
27. Leclercq, V., Lebastard, M., Belkaid, Y., Louis, J., and Milon, G. (1996) The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci. J Immunol 157: 4537-4545.
28. Loimaranta, V., Tenovuo, J., Koivisto, L., and Karp, M. (1998) Generation of bioluminescent Streptococcus mutans and its usage in rapid analysis of the efficacy of antimicrobial compounds. Antimicrob Agents Chemother 42: 1906-1910.
29. Luker, G.D., Bardill, J.P., Prior, J.L., Pica, C.M., Piwnica-Worms, D., and Leib, D.A. (2002) Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J Virol 76: 12149-12161.
30. Luque-Ortega, J.R., Rivero-Lezcano, O.M., Croft, S.L., and Rivas, L. (2001) In vivo monitoring of intracellular ATP levels in Leishmania donovani promastigotes as a rapid method to screen drugs targeting bioenergetic metabolism. Antimicrob Agents Chemother 45: 1121-1125.
31. Misslitz, A., Mottram, J.C., Overath, P., and Aebischer, T. (2000) Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in Leishmania amastigotes. Mol Biochem Parasitol 107: 251-261.
32. Nicolas, L., Milon, G., and Prina, E. (2002) Rapid differentiation of Old World Leishmania species by LightCycler polymerase chain reaction and melting curve analysis. J Microbiol Methods 51: 295-299.
33. Noyes, H.A., Reyburn, H., Bailey, J.W., and Smith, D. (1998) A nested-PCR-based schizodeme method for identifying Leishmania kinetoplast minicircle classes directly from clinical samples and its application to the study of the epidemiology of Leishmania tropica in Pakistan. [see comments] J Clin Microbiol 36: 2877-2881.
34. Prina, E., Jouanne, C., de Souza Lao, S., Szabo, A., Guillet, J.G., and Antoine, J.-C. (1993) Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes. J Immunol 151: 2050-2061.
35. Rocchetta, H.L., Boylan, C.J., Foley, J.W., Iversen, P.W., Letourneau, D.L., McMillian, C.L., et al. (2001) Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection. Antimicrob Agents Chemother 45: 129-137.
36. Roy, G., Dumas, C., Sereno, D., Wu, Y., Singh, A.K., Tremblay, M.J., et al. (2000) Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models. Mol Biochem Parasitol 110: 195-206.
37. Sereno, D., Cavaleyra, M., Zemzoumi, K., Maquaire, S., Ouaissi, A., and Lemesre, J.L. (1998) Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action. Antimicrob Agents Chemother 42: 3097-3102.
38. Sereno, D., Roy, G., Lemesre, J.L., Papadopoulou, B., and Ouellette, M. (2001) DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening. Antimicrob Agents Chemother 45: 1168-1173.
39. Sorensen, M., Lippuner, C., Kaiser, T., Misslitz, A., Aebischer, T., and Bumann, D. (2003) Rapidly maturing red fluorescent protein variants with strongly enhanced brightness in bacteria. FEBS Lett 552: 110-114.
40. Spath, G.F., and Beverley, S.M. (2001) A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 99: 97-103.
41. Strijbosch, L.W., Buurman, W.A., Does, R.J., Zinken, P.H., and Groenewegen, G. (1987) Limiting dilution assays. Experimental design and statistical analysis. J Immunol Methods 97: 133-140.
42. Taswell, C. (1981) Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 126: 1614-1619.
43. Titus, R.G., Marchand, M., Boon, T., and Louis, J.A. (1985) A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 7: 545-555.